Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Muenst S.,,"Frequency, phenotype, and genotype of minute gastrointestinal stromal tumors in the stomach: An autopsy study",2011,Human Pathology,29,10.1016/j.humpath.2011.01.024,Switzerland,Article,Basel,0,Journal,2-s2.0-80955133889
Sawaki A.,,Phase 2 study of nilotinib as third-line therapy for patients with gastrointestinal stromal tumor,2011,Cancer,55,10.1002/cncr.26120,Japan,Article,Nagoya,0,Journal,2-s2.0-79959985933
Pantaleo M.A.,,SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing,2011,Journal of the National Cancer Institute,106,10.1093/jnci/djr130,Italy,Article,Bologna,1,Journal,2-s2.0-79959715470
Eide C.A.,,The ABL switch control inhibitor DCC-2036 is active against the chronic myeloid leukemia mutant BCR-ABL<sup>T315I</sup> and exhibits a narrow resistance profile,2011,Cancer Research,73,10.1158/0008-5472.CAN-10-3224,United States;United States,Article,Portland;Chevy Chase,1,Journal,2-s2.0-79955485779
Demetri G.,,Differential properties of current tyrosine kinase inhibitors in gastrointestinal stromal tumors,2011,Seminars in Oncology,51,10.1053/j.seminoncol.2011.01.018,United States,Article,Boston,0,Journal,2-s2.0-79952763618
Koelz M.,,Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors,2011,International Journal of Oncology,41,10.3892/ijo.2010.857,Austria,Article,Vienna,1,Journal,2-s2.0-78651243203
Dissanayake K.,,ERK/p90<sup>RSK</sup>/14-3-3 signalling has an impact on expression of PEA3 Ets transcription factors via the transcriptional repressor capicúa,2011,Biochemical Journal,68,10.1042/BJ20101562,United Kingdom,Article,Dundee,1,Journal,2-s2.0-78751532247
Ylipää A.,,Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors,2011,Cancer,32,10.1002/cncr.25594,United States;Finland,Article,Houston;Tampere,0,Journal,2-s2.0-78650972191
Janeway K.A.,,Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations,2011,Proceedings of the National Academy of Sciences of the United States of America,379,10.1073/pnas.1009199108,United States,Article,Boston,1,Journal,2-s2.0-78651082042
Reynoso D.,,Synergistic induction of apoptosis by the Bcl-2 inhibitor ABT-737 and imatinib mesylate in gastrointestinal stromal tumor cells,2011,Molecular Oncology,30,10.1016/j.molonc.2010.10.003,United States;United States,Article,Houston;Houston,1,Journal,2-s2.0-78951493598
Chi P.,,ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours,2010,Nature,194,10.1038/nature09409,United States;United States,Article,New York;New York,0,Journal,2-s2.0-77957943127
Rossi S.,,Molecular and clinicopathologic characterization of gastrointestinal stromal tumors (GISTs) of small size,2010,American Journal of Surgical Pathology,83,10.1097/PAS.0b013e3181ef7431,Italy,Article,Treviso,0,Journal,2-s2.0-77957969688
Le Cesne A.,,Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: An open-label multicentre randomised phase 3 trial,2010,The Lancet Oncology,193,10.1016/S1470-2045(10)70222-9,France,Article,Villejuif,0,Journal,2-s2.0-77957341199
Hur K.,,Gene expression profiling of human gastrointestinal stromal tumors according to its malignant potential,2010,Digestive Diseases and Sciences,13,10.1007/s10620-009-1061-4,South Korea,Article,Seoul,0,Journal,2-s2.0-77956183484
Gupta A.,,Autophagy inhibition and antimalarials promote cell death in gastrointestinal stromal tumor (GIST),2010,Proceedings of the National Academy of Sciences of the United States of America,133,10.1073/pnas.1000248107,United States,Article,Cleveland,1,Journal,2-s2.0-77956282607
Wong N.,,Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour,2010,Histopathology,32,10.1111/j.1365-2559.2010.03622.x,United Kingdom,Article,Bristol,0,Journal,2-s2.0-77955816314
Novelli M.,,DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours,2010,Histopathology,118,10.1111/j.1365-2559.2010.03624.x,United Kingdom,Article,London,0,Journal,2-s2.0-77955817308
Dorn J.,,Cyclin H expression is increased in GIST with very-high risk of malignancy,2010,BMC Cancer,9,10.1186/1471-2407-10-350,Germany,Article,Ulm,1,Journal,2-s2.0-77954038824
Schöffski P.,,A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors,2010,Annals of Oncology,83,10.1093/annonc/mdq076,Belgium,Article,3000 Leuven,1,Journal,2-s2.0-77957171405
Gordon P.,,Role for the proapoptotic factor BIM in mediating imatinib-induced apoptosis in a c-KIT-dependent gastrointestinal stromal tumor cell line,2010,Journal of Biological Chemistry,26,10.1074/jbc.M109.078592,United States;United States;United States;United States,Article,Boston;Boston;Boston;Boston,1,Journal,2-s2.0-77952004119
Cullinane C.,,Preclinical evaluation of nilotinib efficacy in an imatinib-resistant KIT-driven tumor model,2010,Molecular Cancer Therapeutics,23,10.1158/1535-7163.MCT-09-1181,Australia,Article,Melbourne,1,Journal,2-s2.0-77952121301
Linehan W.,,The genetic basis of kidney cancer: A metabolic disease,2010,Nature Reviews Urology,459,10.1038/nrurol.2010.47,United States,Review,Bethesda,0,Journal,2-s2.0-77952263737
Van Glabbeke M.,,"Comparison of two doses of imatinib for the treatment of unresectable or metastatic gastrointestinal stromal tumors: A meta-analysis of 1,640 patients",2010,Journal of Clinical Oncology,321,10.1200/JCO.2009.24.2099,,Article,,0,Journal,2-s2.0-77949898532
Bardsley M.R.,,Kit<sup>low</sup> stem cells cause resistance to kit/platelet-derived growth factor α inhibitors in murine gastrointestinal stromal tumors,2010,Gastroenterology,78,10.1053/j.gastro.2010.05.083,United States,Article,Rochester,0,Journal,2-s2.0-77956146147
Hostein I.,,BRAF mutation status in gastrointestinal stromal tumors,2010,American Journal of Clinical Pathology,149,10.1309/AJCPPCKGA2QGBJ1R,France,Article,Bordeaux,1,Journal,2-s2.0-73949094832
Chibon F.,,Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity,2010,Nature Medicine,241,10.1038/nm.2174,France;France,Article,Bordeaux;Paris,0,Journal,2-s2.0-77954535843
Huang H.,,Homozygous deletion of MTAP gene as a poor prognosticator in gastrointestinal stromal tumors,2009,Clinical Cancer Research,27,10.1158/1078-0432.CCR-09-1511,Taiwan,Article,Taoyuan,1,Journal,2-s2.0-72549086600
Janeway K.,,Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib,2009,Pediatric Blood and Cancer,105,10.1002/pbc.21909,United States,Article,Boston,0,Journal,2-s2.0-67650472798
Agaimy A.,,V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wildtype gastrointestinal stromal tumours,2009,Journal of Clinical Pathology,144,10.1136/jcp.2009.064550,Germany;Germany,Article,Erlangen;Erlangen,0,Journal,2-s2.0-67650480850
Romeo S.,,Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors,2009,Clinical Cancer Research,53,10.1158/1078-0432.CCR-08-3297,Netherlands,Article,Leiden,1,Journal,2-s2.0-67449168370
Yamamoto H.,,Neurofibromatosis type 1-related gastrointestinal stromal tumors: A special reference to loss of heterozygosity at 14q and 22q,2009,Journal of Cancer Research and Clinical Oncology,42,10.1007/s00432-008-0514-z,Japan,Article,Fukuoka,0,Journal,2-s2.0-67349281927
Gomez-Pinilla P.,,Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract,2009,American Journal of Physiology - Gastrointestinal and Liver Physiology,261,10.1152/ajpgi.00074.2009,United States,Article,Rochester,0,Journal,2-s2.0-67049115838
Nishida T.,,Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene,2009,International Journal of Clinical Oncology,47,10.1007/s10147-008-0822-y,Japan,Article,Suita,0,Journal,2-s2.0-65349155963
Gajiwaia K.,,KIT kinase mutants show unique mechanisms of drug resistance to imatinib and sunitinib in gastrointestinal stromal tumor patients,2009,Proceedings of the National Academy of Sciences of the United States of America,255,10.1073/pnas.0812413106,United States,Article,New York,1,Journal,2-s2.0-60849113175
Sakurama K.,,Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor,2009,Molecular Cancer Therapeutics,62,10.1158/1535-7163.MCT-08-0884,Japan,Article,Okayama,1,Journal,2-s2.0-58149484784
DeMatteo R.,,"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial",20090328/0403,The Lancet,936,10.1016/S0140-6736(09)60500-6,United States,Article,New York,0,Journal,2-s2.0-62849096370
Heinrich M.,,Correlation of kinase genotype and clinical outcome in the North American intergroup phase III trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 study by cancer and leukemia group B and southwest oncology group,2008,Journal of Clinical Oncology,423,10.1200/JCO.2008.17.4284,United States,Article,Portland,0,Journal,2-s2.0-56749156604
Heinrich M.C.,,Primary and secondary kinase genotypes correlate with the biological and clinical activity of sunitinib in imatinib-resistant gastrointestinal stromal tumor,2008,Journal of Clinical Oncology,500,10.1200/JCO.2007.15.7461,United States,Article,San Diego,0,Journal,2-s2.0-56749098278
Agaram N.,,Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors,2008,Genes Chromosomes and Cancer,257,10.1002/gcc.20589,United States,Article,New York,0,Journal,2-s2.0-50249152932
Gasparotto D.,,Multiple primary sporadic gastrointestinal stromal tumors in the adult: An underestimated entity,2008,Clinical Cancer Research,44,10.1158/1078-0432.CCR-08-0622,Italy,Article,Aviano,1,Journal,2-s2.0-53249101820
Ricketts C.,,Germline SDHB mutations and familial renal cell carcinoma,2008,Journal of the National Cancer Institute,255,10.1093/jnci/djn254,United Kingdom,Article,Birmingham,1,Journal,2-s2.0-51749113159
Liegl B.,,Heterogeneity of kinase inhibitor resistance mechanisms in GIST,2008,Journal of Pathology,276,10.1002/path.2382,United States;Austria,Article,Boston;Graz,0,Journal,2-s2.0-50249092801
Chen L.L.,,Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression,2008,Modern Pathology,31,10.1038/modpathol.2008.46,United States,Article,Salt Lake City,1,Journal,2-s2.0-46049097771
Tarn C.,,Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors,2008,Proceedings of the National Academy of Sciences of the United States of America,194,10.1073/pnas.0803383105,United States,Article,Philadelphia,1,Journal,2-s2.0-46149104384
Lim K.,,Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors,2008,Medical Oncology,41,10.1007/s12032-007-9014-2,Taiwan;Taiwan,Article,Taipei;Taipei,0,Journal,2-s2.0-48049101758
Agaimy A.,,"Microscopic gastrointestinal stromal tumors in esophageal and intestinal surgical resection specimens: A clinicopathologic, immunohistochemical, and molecular study of 19 lesions",2008,American Journal of Surgical Pathology,60,10.1097/PAS.0b013e31815c0417,Germany;Germany,Article,Nurnberg;Nurnberg,0,Journal,2-s2.0-46249114153
Agaram N.,,Molecular characterization of pediatric gastrointestinal stromal tumors,2008,Clinical Cancer Research,196,10.1158/1078-0432.CCR-07-1984,United States,Article,New York,1,Journal,2-s2.0-49649119001
Nishida T.,,Secondary mutations in the kinase domain of the KIT gene are predominant in imatinib-resistant gastrointestinal stromal tumor,2008,Cancer Science,74,10.1111/j.1349-7006.2008.00727.x,Japan,Article,Suita,1,Journal,2-s2.0-41349109537
Lasota J.,,Clinicopathologic profile of gastrointestinal stromal tumors (GISTs) with primary KIT exon 13 or exon 17 mutations: A multicenter study on 54 cases,2008,Modern Pathology,117,10.1038/modpathol.2008.2,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-41149170835
Abhyankar S.,,Highlighting the role of FDG PET scan in early response assessment of gastrointestinal stromal tumor treated with imatinib mesylate,2008,Clinical Nuclear Medicine,10,10.1097/RLU.0b013e318162db8d,India,Article,Mumbai,0,Journal,2-s2.0-39749114428
Blanke C.,,Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT,2008,Journal of Clinical Oncology,723,10.1200/JCO.2007.13.4403,Finland,Article,Helsinki,0,Journal,2-s2.0-39149123549
Blanke C.D.,,"Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033",2008,Journal of Clinical Oncology,746,10.1200/JCO.2007.13.4452,United States,Article,Portland,0,Journal,2-s2.0-39149127634
Bauer S.,,KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway,2007,Oncogene,182,10.1038/sj.onc.1210558,United States,Article,Boston,1,Journal,2-s2.0-36749030022
Janeway K.A.,,Pediatric KIT-wild-type and platelet-derived growth factor receptor α-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors,2007,Cancer Research,123,10.1158/0008-5472.CAN-07-1938,United States;United States;United States,Article,Boston;Boston;Boston,1,Journal,2-s2.0-35148813515
Guo T.,,Sorafenib inhibits the imatinib-resistant KIT<sup>T670I</sup> gatekeeper mutation in gastrointestinal stromal tumor,2007,Clinical Cancer Research,120,10.1158/1078-0432.CCR-07-0484,United States,Article,New York,1,Journal,2-s2.0-34548061196
Yuzawa S.,,Structural Basis for Activation of the Receptor Tyrosine Kinase KIT by Stem Cell Factor,2007,Cell,218,10.1016/j.cell.2007.05.055,United States,Article,New Haven,1,Journal,2-s2.0-34447531743
Mahadevan D.,,A novel tyrosine kinase switch is a mechanism of imatinib resistance in gastrointestinal stromal tumors,2007,Oncogene,204,10.1038/sj.onc.1210173,United States,Article,Tucson,1,Journal,2-s2.0-34249985524
Ässämäki R.,,Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors,2007,Genes Chromosomes and Cancer,55,10.1002/gcc.20439,Finland,Article,Helsinki,0,Journal,2-s2.0-34247472067
Choi H.,,Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria,2007,Journal of Clinical Oncology,1054,10.1200/JCO.2006.07.3049,United States,Article,Houston,0,Journal,2-s2.0-34249085905
Liu Y.,,Histone H2AX is a mediator of gastrointestinal stromal tumor cell apoptosis following treatment with imatinib mesylate,2007,Cancer Research,71,10.1158/0008-5472.CAN-06-3497,United States,Article,Pittsburgh,1,Journal,2-s2.0-34047270774
Roberts K.G.,,Resistance to c-KIT kinase inhibitors conferred by V654A mutation,2007,Molecular Cancer Therapeutics,67,10.1158/1535-7163.MCT-06-0641,Australia,Article,Newcastle,1,Journal,2-s2.0-34147187338
Gunawan B.,,An oncogenetic tree model in gastrointestinal stromal tumours (GISTs) identifies different pathways of cytogenic evolution with prognostic implications,2007,Journal of Pathology,77,10.1002/path.2128,Germany,Article,Gottingen,0,Journal,2-s2.0-33847371195
Wozniak A.,,"Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status",2007,Genes Chromosomes and Cancer,86,10.1002/gcc.20408,Belgium;Poland,Article,3000 Leuven;Gdańsk,0,Journal,2-s2.0-33846556710
Kang D.,,Multiple gastrointestinal stromal tumors: Clinicopathologic and genetic analysis of 12 patients,2007,American Journal of Surgical Pathology,84,10.1097/01.pas.0000213318.66800.94,South Korea,Article,Daejeon,0,Journal,2-s2.0-33846567566
Matei D.,,The platelet-derived growth factor receptor α is destabilized by geldanamycins in cancer cells,2007,Journal of Biological Chemistry,54,10.1074/jbc.M607012200,United States;United States,Article,Indianapolis;Indianapolis,1,Journal,2-s2.0-33846982944
Stewart D.R.,,Mitotic recombination as evidence of alternative pathogenesis of gastrointestinal stromal tumours in neurofibromatosis type 1.,2007,Journal of medical genetics,45,10.1136/jmg.2006.043075,,Letter,,0,Journal,2-s2.0-33846924623
Agaram N.,,Pathologic and molecular heterogeneity in imatinib-stable or imatinib-responsive gastrointestinal stromal tumors,2007,Clinical Cancer Research,93,10.1158/1078-0432.CCR-06-1508,United States,Article,New York,1,Journal,2-s2.0-33846277973
Xiang Z.,,"Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling",2007,Molecular and Cellular Biology,89,10.1128/MCB.01153-06,United States,Article,St. Louis,1,Journal,2-s2.0-33845751024
Agaimy A.,,Minute Gastric Sclerosing Stromal Tumors (GIST Tumorlets) are common in adults and frequently show c-KIT mutations,2007,American Journal of Surgical Pathology,255,10.1097/01.pas.0000213307.05811.f0,Germany;Germany,Article,Nurnberg;Nurnberg,0,Journal,2-s2.0-33845940073
Kawanowa K.,,High incidence of microscopic gastrointestinal stromal tumors in the stomach,2006,Human Pathology,252,10.1016/j.humpath.2006.07.002,Japan;Japan,Article,Tokyo;Kitaadachi District,0,Journal,2-s2.0-33751225088
Komuro T.,,Structure and organization of interstitial cells of Cajal in the gastrointestinal tract,2006,Journal of Physiology,120,10.1113/jphysiol.2006.116624,Japan,Article,Tokyo,0,Journal,2-s2.0-33750411906
Loughrey M.,,Polyclonal resistance in gastrointestinal stromal tumor treated with sequential kinase inhibitors [3],2006,Clinical Cancer Research,12,10.1158/1078-0432.CCR-06-1079,United Kingdom,Letter,Belfast,1,Journal,2-s2.0-33750729938
Demetri G.,,Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial,2006,Lancet,1884,10.1016/S0140-6736(06)69446-4,United States,Article,Boston,0,Journal,2-s2.0-33749505836
Heinrich M.,,Molecular correlates of imatinib resistance in gastrointestinal stromal tumors,2006,Journal of Clinical Oncology,613,10.1200/JCO.2006.06.2265,,Article,,0,Journal,2-s2.0-33750595859
Bauer S.,,Heat shock protein 90 inhibition in imatinib-resistant gastrointestinal stromal tumor,2006,Cancer Research,202,10.1158/0008-5472.CAN-06-0165,United States;Germany,Article,Boston;Essen,1,Journal,2-s2.0-33749461709
Schurr P.,,Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcome,2006,Clinical Cancer Research,17,10.1158/1078-0432.CCR-05-2083,Germany,Article,Hamburg,1,Journal,2-s2.0-33749036310
Rossi F.,,Oncogenic Kit signaling and therapeutic intervention in a mouse model of gastrointestinal stromal tumor,2006,Proceedings of the National Academy of Sciences of the United States of America,92,10.1073/pnas.0511076103,United States,Article,New York,1,Journal,2-s2.0-33748059560
Koyama T.,,Recurrent gastrointestinal stromal tumor (GIST) of the stomach associated with a novel c-kit mutation after imatinib treatment,2006,Gastric Cancer,17,10.1007/s10120-006-0368-5,Japan,Article,Tokyo,1,Journal,2-s2.0-33748891958
Debiec-Rychter M.,,KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours,2006,European Journal of Cancer,668,10.1016/j.ejca.2006.01.030,Belgium,Article,3000 Leuven,0,Journal,2-s2.0-33746401591
Chan K.,,Gastrointestinal stromal tumors in a cohort of Chinese patients in Hong Kong,2006,World Journal of Gastroenterology,48,10.3748/wjg.v12.i14.2223,China,Article,Hong Kong,1,Journal,2-s2.0-33646267674
Miettinen M.,,"Gastrointestinal stromal tumors of the jejunum and ileum: A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up",2006,American Journal of Surgical Pathology,457,10.1097/00000478-200604000-00008,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-33646685694
Wardelmann E.,,Polyclonal evolution of multiple secondary KIT mutations in gastrointestinal stromal tumors under treatment with imatinib mesylate,2006,Clinical Cancer Research,274,10.1158/1078-0432.CCR-05-1211,Germany,Article,Bonn,1,Journal,2-s2.0-33645693156
Maertens O.,,Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients,2006,Human Molecular Genetics,169,10.1093/hmg/ddl016,Belgium,Article,Ghent,1,Journal,2-s2.0-33644781795
Cho S.,,Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach,2006,International Journal of Oncology,43,10.3892/ijo.28.6.1361,Japan,Article,Hiroshima,1,Journal,2-s2.0-33747144590
Weisberg E.,,"Effects of PKC412, Nilotinib, and Imatinib Against GIST-Associated PDGFRA Mutants With Differential Imatinib Sensitivity",2006,Gastroenterology,86,10.1053/j.gastro.2006.09.017,United States,Article,Boston,0,Journal,2-s2.0-33845601781
Lasota J.,,GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioid morphology,2006,Laboratory Investigation,115,10.1038/labinvest.3700360,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-32844458682
Andersson J.,,Gastrointestinal Stromal Tumors With KIT Exon 11 Deletions Are Associated With Poor Prognosis,2006,Gastroenterology,180,10.1053/j.gastro.2006.01.043,Sweden,Article,Gothenburg,0,Journal,2-s2.0-33646381326
Miettinen M.,,Gastrointestinal stromal tumors in patients with neurofibromatosis 1: A clinicopathologic and molecular genetic study of 45 cases,2006,American Journal of Surgical Pathology,319,10.1097/01.pas.0000176433.81079.bd,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-33644752349
Goettsch W.,,Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study,2005,European Journal of Cancer,234,10.1016/j.ejca.2005.09.009,Netherlands,Article,Utrecht,0,Journal,2-s2.0-28244441991
Martín J.,,Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: A study by the Spanish Group for Sarcoma Research (GEIS),2005,Journal of Clinical Oncology,263,10.1200/JCO.2005.19.554,Spain,Article,Palma,0,Journal,2-s2.0-24944536236
Corless C.,,"PDGFRA mutations in gastrointestinal stromal tumors: Frequency, spectrum and in vitro sensitivity to imatinib",2005,Journal of Clinical Oncology,587,10.1200/JCO.2005.14.068,,Article,,0,Journal,2-s2.0-23944476156
Tryggvason G.,,"Gastrointestinal stromal tumors in Iceland, 1990-2003: The Icelandic GIST study, a population-based incidence and pathologic risk stratification study",2005,International Journal of Cancer,261,10.1002/ijc.21167,Iceland,Article,Reykjavik,1,Journal,2-s2.0-25444448316
Grimpen F.,,"Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour",2005,Lancet Oncology,34,10.1016/S1470-2045(05)70321-1,Australia,Article,Canberra,0,Journal,2-s2.0-24044434901
Andersson J.,,"NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics",2005,American Journal of Surgical Pathology,191,10.1097/01.pas.0000159775.77912.15,Sweden,Article,Gothenburg,0,Journal,2-s2.0-24144477000
Rubin B.,,A knock-in mouse model of gastrointestinal stromal tumor harboring Kit K641E,2005,Cancer Research,114,10.1158/0008-5472.CAN-05-0891,United States,Article,Seattle,1,Journal,2-s2.0-23044467277
Liu X.,,Prognostic value of KIT mutation in gastrointestinal stromal tumors,2005,World Journal of Gastroenterology,23,10.3748/wjg.v11.i25.3948,China,Article,Shanghai,0,Journal,2-s2.0-22644431820
Perrone F.,,9p21 locus analysis in high-risk gastrointestinal stromal tumors characterized for c-kit and platelet-derived growth factor receptor α gene alterations,2005,Cancer,51,10.1002/cncr.21113,Italy,Article,Milan,1,Journal,2-s2.0-20544445201
Tornillo L.,,Patterns of gene amplification in gastrointestinal stromal tumors (GIST),2005,Laboratory Investigation,54,10.1038/labinvest.3700284,Switzerland,Article,Basel,1,Journal,2-s2.0-22544452099
Nakamura N.,,Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade,2005,Human Pathology,114,10.1016/j.humpath.2005.03.012,Japan,Article,Fukuoka,0,Journal,2-s2.0-23444443877
Antonescu C.,,Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation,2005,Clinical Cancer Research,619,10.1158/1078-0432.CCR-04-2245,United States,Article,New York,1,Journal,2-s2.0-20344393896
Wardelmann E.,,Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations,2005,Lancet Oncology,134,10.1016/S1470-2045(05)70097-8,Germany;Germany,Article,Bonn;Bonn,0,Journal,2-s2.0-20144387198
Prakash S.,,"Gastrointestinal stromal tumors in children and young adults: A clinicopathologic, molecular, and genomic study of 15 cases and review of the literature",2005,Journal of Pediatric Hematology/Oncology,208,10.1097/01.mph.0000157790.81329.47,United States,Conference Paper,New York,0,Journal,2-s2.0-20944442418
Feakins R.M.,,"The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome",2005,Histopathology,50,10.1111/j.1365-2559.2005.02071.x,United Kingdom;United Kingdom,Article,London;London,0,Journal,2-s2.0-14844314779
Motegi A.,,"PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors",2005,Pathology International,80,10.1111/j.1440-1827.2005.01806.x,Japan,Article,Maebashi,0,Journal,2-s2.0-16444380600
Tzen C.,,Analysis of CD117-negative gastrointestinal stromal tumors,2005,World Journal of Gastroenterology,35,10.3748/wjg.v11.i7.1052,Taiwan;Taiwan;Taiwan;Taiwan,Article,Taipei;Taipei;Taipei;Taipei,1,Journal,2-s2.0-14844317303
Nilsson B.,,"Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era - A population-based study in western Sweden",2005,Cancer,904,10.1002/cncr.20862,Sweden,Review,Gothenburg,0,Journal,2-s2.0-13444270334
Kang H.J.,,Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors,2005,Oncogene,76,10.1038/sj.onc.1208358,South Korea,Article,Seoul,1,Journal,2-s2.0-20044383730
Pauls K.,,PDGFRα- and c-kit-mutated gastrointestinal stromal tumours (GISTs) are characterized by distinctive histological and immunohistochemical features,2005,Histopathology,107,10.1111/j.1365-2559.2005.02061.x,Germany;Germany,Article,Bonn;Bonn,0,Journal,2-s2.0-14344256167
Schneider-Stock R.,,Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: A tissue microarray study,2005,Clinical Cancer Research,109,,Germany,Article,Magdeburg,0,Journal,2-s2.0-19944427609
O'Riain C.,,Gastrointestinal stromal tumors: Insights from a new familial GIST kindred with unusual genetic and pathologic features,2005,American Journal of Surgical Pathology,63,10.1097/01.pas.0000173024.79852.08,Ireland,Conference Paper,Dublin,0,Journal,2-s2.0-33644812236
Debiec-Rychter M.,,Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants,2005,Gastroenterology,410,10.1053/j.gastro.2004.11.020,Belgium,Article,3000 Leuven,0,Journal,2-s2.0-14944352767
Miettinen M.,,"Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up",2005,American Journal of Surgical Pathology,938,10.1097/01.pas.0000146010.92933.de,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-11144284051
Sabah M.,,Loss of heterozygosity of chromosome 9p and loss of p16<sup>INK4A</sup> expression are associated with malignant gastrointestinal stromal tumors,2004,Modern Pathology,53,10.1038/modpathol.3800199,Ireland,Article,Dublin,1,Journal,2-s2.0-8144222050
Subramanian S.,,Gastrointestinal stromal tumors (GISTs) with KIT and PDGFRA mutations have distinct gene expression profiles,2004,Oncogene,115,10.1038/sj.onc.1208056,United States,Article,Stanford,1,Journal,2-s2.0-7644242712
Sakurai S.,,Myxoid epithelioid gastrointestinal stromal tumor (GIST) with mast cell infiltrations: A subtype of GIST with mutations of platelet-derived growth factor receptor alpha gene,2004,Human Pathology,80,10.1016/j.humpath.2004.07.008,Japan,Article,Kawachi District,0,Journal,2-s2.0-5444222014
Verweij J.,,Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: Randomised trial,2004,Lancet,1318,10.1016/S0140-6736(04)17098-0,Netherlands,Article,Rotterdam,0,Journal,2-s2.0-20844433223
Chen L.,,A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors,2004,Cancer Research,292,10.1158/0008-5472.CAN-04-0085,United States,Article,Houston,1,Journal,2-s2.0-20844460619
Wasag B.,,Differential expression of KIT/PDGFRA mutant isoforms in epithelioid and mixed variants of gastrointestinal stromal tumors depends predominantly on the tumor site,2004,Modern Pathology,87,10.1038/modpathol.3800136,Belgium;Poland,Article,Leuven;Gdańsk,1,Journal,2-s2.0-3342991696
Duensing A.,,Protein kinase C θ (PKC θ) expression and constitutive activation in gastrointestinal stromal tumors (GISTs),2004,Cancer Research,106,10.1158/0008-5472.CAN-04-0559,United States;United States,Article,Pittsburgh;Boston,0,Journal,2-s2.0-3442881363
Mol C.,,Structural basis for the autoinhibition and STI-571 inhibition of c-Kit tyrosine kinase,2004,Journal of Biological Chemistry,471,10.1074/jbc.M403319200,United States,Article,San Diego,1,Journal,2-s2.0-2942542387
Lasota J.,,A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential,2004,Laboratory Investigation,236,10.1038/labinvest.3700122,United States,Article,"Washington, D.C.",1,Journal,2-s2.0-3042646931
Medeiros F.,,KIT-negative gastrointestinal stromal tumors: Proof of concept and therapeutic implications,2004,American Journal of Surgical Pathology,382,10.1097/00000478-200407000-00007,United States,Article,Boston,0,Journal,2-s2.0-2142747025
Wakai T.,,Late resistance to imatinib therapy in a metastatic gastrointestinal stromal tumour is associated with a second KIT mutation,2004,British Journal of Cancer,86,10.1038/sj.bjc.6601819,Japan,Article,Niigata,1,Journal,2-s2.0-3042747267
Antonescu C.,,Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site,2004,Clinical Cancer Research,171,10.1158/1078-0432.CCR-03-0715,United States,Article,New York,1,Journal,2-s2.0-2542462086
Duensing A.,,Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs),2004,Oncogene,256,10.1038/sj.onc.1207525,United States;United States,Article,Pittsburgh;Boston,1,Journal,2-s2.0-2542520755
Debiec-Rychter M.,,Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity,2004,Journal of Pathology,171,10.1002/path.1546,Belgium;Belgium,Article,Leuven;3000 Leuven,0,Journal,2-s2.0-1842426806
Fumo G.,,"17-Allylamino-17-demethoxygeldanamycin (17-AAG) is effective in down-regulating mutated, constitutively activated KIT protein in human mast cells",2004,Blood,132,10.1182/blood-2003-07-2477,,Article,,0,Journal,2-s2.0-1642541150
Poole D.,,Protein kinases expressed by interstitial cells of Cajal,2004,Histochemistry and Cell Biology,30,10.1007/s00418-003-0602-8,Australia,Article,Parkville,0,Journal,2-s2.0-1042288608
Corless C.,,KIT gene deletions at the intron 10-exon 11 boundary in GI stromal tumors,2004,Journal of Molecular Diagnostics,40,10.1016/S1525-1578(10)60533-8,United States;United States,Article,Portland;Portland,0,Journal,2-s2.0-8744270203
Ricci R.,,Role of p16/INK4a in gastrointestinal stromal tumor progression,2004,American Journal of Clinical Pathology,54,10.1309/MJ4XN2M57HNC8X5H,Italy,Article,Rome,1,Journal,2-s2.0-3042723785
Wardelmann E.,,Association of platelet-derived growth factor receptor α mutations with gastric primary site and epithelioid or mixed cell morphology in gastrointestinal stromal tumors,2004,Journal of Molecular Diagnostics,137,10.1016/S1525-1578(10)60510-7,Germany,Article,Bonn,0,Journal,2-s2.0-4344611744
Kinoshita K.,,Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type I patients,2004,Journal of Pathology,149,10.1002/path.1487,Japan,Article,Suita,0,Journal,2-s2.0-0346025449
Chompret A.,,PDGFRA Germline Mutation in a Family with Multiple Cases of Gastrointestinal Stromal Tumor,2004,Gastroenterology,173,10.1053/j.gastro.2003.10.079,France,Article,Villejuif,0,Journal,2-s2.0-0347361543
Tamborini E.,,A new mutation in the KIT ATP pocket causes acquired resistance to imatinib in a gastrointestinal stromal tumor patient,2004,Gastroenterology,279,10.1053/j.gastro.2004.02.021,Italy,Article,Milan,0,Journal,2-s2.0-20844448396
West R.B.,,"The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status",2004,American Journal of Pathology,456,10.1016/S0002-9440(10)63279-8,United States,Article,Stanford,0,Journal,2-s2.0-3042594995
Heinrich M.,,Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor,2003,Journal of Clinical Oncology,1796,10.1200/JCO.2003.04.190,,Article,,0,Journal,2-s2.0-0642368571
Wardelmann E.,,Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors,2003,International Journal of Cancer,194,10.1002/ijc.11323,Germany;Germany,Article,Bonn;Bonn,1,Journal,2-s2.0-0042338788
Pruneri G.,,Cyclin D3 immunoreactivity in gastrointestinal stromal tumors is independent of cyclin D3 gene amplification and is associated with nuclear p27 accumulation,2003,Modern Pathology,24,10.1097/01.MP.0000085026.38856.B9,Italy,Article,Milan,1,Journal,2-s2.0-0141519092
Antonescu C.,,Association of KIT exon 9 mutations with nongastric primary site and aggressive behavior: KIT mutation analysis and clinical correlates of 120 gastrointestinal stromal tumors,2003,Clinical Cancer Research,299,,United States,Article,New York,0,Journal,2-s2.0-10744225271
Hirota S.,,Gain-of-function mutations of platelet-derived growth factor receptor α gene in gastrointestinal stromal tumors,2003,Gastroenterology,574,10.1016/S0016-5085(03)01046-1,Japan,Article,Suita,0,Journal,2-s2.0-0041971080
Mol C.D.,,Structure of a c-Kit product complex reveals the basis for kinase transactivation,2003,Journal of Biological Chemistry,192,10.1074/jbc.C300186200,,Article,,1,Journal,2-s2.0-0042357240
Sommer G.,,Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase,2003,Proceedings of the National Academy of Sciences of the United States of America,189,10.1073/pnas.1037763100,United States,Article,New York,1,Journal,2-s2.0-0038312141
Schneider-Stock R.,,High prognostic value of p16<sup>INK4</sup> alterations in gastrointestinal stromal tumors,2003,Journal of Clinical Oncology,138,10.1200/JCO.2003.08.101,Germany,Article,Magdeburg,0,Journal,2-s2.0-0038135029
Miettinen M.,,"Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the duodenum: A clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases",2003,American Journal of Surgical Pathology,336,10.1097/00000478-200305000-00006,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-0037407876
Southwell B.,,Localization of protein kinase C theta immunoreactivity to interstitial cells of Cajal in guinea-pig gastrointestinal tract,2003,Neurogastroenterology and Motility,29,10.1046/j.1365-2982.2003.00394.x,Australia,Article,Melbourne,0,Journal,2-s2.0-0037732988
Heinrich M.C.,,PDGFRA activating mutations in gastrointestinal stromal tumors,2003,Science,1808,10.1126/science.1079666,United States,Article,Portland,0,Journal,2-s2.0-0242670019
Lasota J.,,KIT 1530ins6 Mutation Defines a Subset of Predominantly Malignant Gastrointestinal Stromal Tumors of Intestinal Origin,2003,Human Pathology,79,10.1016/S0046-8177(03)00407-6,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-9144241089
Chen H.,,Polyclonal nature of diffuse proliferation of interstitial cells of Cajal in patients with familial and multiple gastrointestinal stromal tumours,2002,Gut,81,10.1136/gut.51.6.793,Japan,Article,Suita,1,Journal,2-s2.0-0036895022
Singer S.,,"Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors",2002,Journal of Clinical Oncology,384,10.1200/JCO.2002.03.095,United States,Article,Boston,0,Journal,2-s2.0-0037106370
Sarlomo-Rikala M.,,"Patterns of nestin and other intermediate filament expression distinguish between gastrointestinal stromal tumors, leiomyomas and schwannomas",2002,APMIS,62,10.1034/j.1600-0463.2002.100608.x,Finland,Article,Helsinki,0,Journal,2-s2.0-0036337887
Demetri G.D.,,Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors,2002,New England Journal of Medicine,3426,10.1056/NEJMoa020461,United States,Article,Boston,0,Journal,2-s2.0-0037103424
Weinstein I.,,Cancer: Addiction to oncogenes - The Achilles heal of cancer,2002,Science,1343,10.1126/science.1073096,United States,Short Survey,New York,0,Journal,2-s2.0-0037025173
Hirota S.,,Familial gastrointestinal stromal tumors associated with dysphagia and novel type germline mutation of KIT gene,2002,Gastroenterology,178,10.1053/gast.2002.33024,Japan,Article,Suita,0,Journal,2-s2.0-0036240932
Van den Abbeele A.D.,,Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs).,2002,"European journal of cancer (Oxford, England : 1990)",221,10.1016/s0959-8049(02)80604-9,United States,Review,Boston,0,Journal,2-s2.0-0036769690
Heinrich M.C.,,Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations,2002,Human Pathology,406,10.1053/hupa.2002.124124,United States;United States;United States;United States;United States,Article,Seattle;Boston;Portland;Boston;New York,0,Journal,2-s2.0-0036303804
Corless C.L.,,KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size,2002,American Journal of Pathology,381,10.1016/S0002-9440(10)61103-0,United States;United States,Article,Portland;Portland,0,Journal,2-s2.0-0036092268
Dematteo R.,,Clinical management of gastrointestinal stromal tumors: Before and after STI-571,2002,Human Pathology,539,10.1053/hupa.2002.124122,United States;United States;United States;United States,Article,Charlottesville;Portland;Boston;New York,0,Journal,2-s2.0-0036305274
Rubin B.,,KIT activation is a ubiquitous feature of gastrointestinal stromal tumors,2001,Cancer Research,837,,United States,Article,Boston,0,Journal,2-s2.0-0035890740
Tuveson D.,,STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: Biological and clinical implications,2001,Oncogene,580,10.1038/sj.onc.1204704,United States;United States,Article,Cambridge;Boston,1,Journal,2-s2.0-0035899418
Beghini A.,,Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa,2001,Cancer,183,10.1002/1097-0142(20010801)92:3<657::AID-CNCR1367>3.0.CO;2-D,Italy;Italy;Italy,Article,Milan;Varese;Varese,1,Journal,2-s2.0-0035425217
Debiec-Rychter M.,,Chromosomal aberrations in malignant gastrointestinal stromal tumorscorrelation with c-KIT gene mutation,2001,Cancer Genetics and Cytogenetics,104,10.1016/S0165-4608(01)00395-8,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-0035397627
Joensuu H.,,Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor,2001,New England Journal of Medicine,1733,10.1056/NEJM200104053441404,Finland,Article,Helsinki,0,Journal,2-s2.0-0035810148
Maeyama H.,,Familial gastrointestinal stromal tumor with hyperpigmentation: Association with a germline mutation of the c-kit gene,2001,Gastroenterology,199,10.1053/gast.2001.20880,Japan,Article,Nagano,0,Journal,2-s2.0-0035174752
Heinrich M.C.,,Inhibition of c-kit receptor tyrosine kinase activity by STI 571 a selective tyrosine kinase inhibitor,2000,Blood,901,10.1182/blood.v96.3.925.015k50_925_932,United States,Article,Portland,0,Journal,2-s2.0-0034254249
El-Rifai W.,,DNA sequence copy number changes in gastrointestinal stromal tumors: Tumor progression and prognostic significance,2000,Cancer Research,193,,Finland,Article,Helsinki,0,Journal,2-s2.0-0034660868
El-Rifai W.,,High-resolution deletion mapping of chromosome 14 in stromal tumors of the gastrointestinal tract suggests two distinct tumor suppressor loci,2000,Genes Chromosomes and Cancer,73,10.1002/(SICI)1098-2264(200004)27:4<387::AID-GCC8>3.0.CO;2-C,Finland;Egypt,Article,Helsinki;Cairo,0,Journal,2-s2.0-0034006759
Kim N.,,"Putative chromosomal deletions on 9p, 9q and 22q occur preferentially in malignant gastrointestinal stromal tumors",2000,International Journal of Cancer,86,10.1002/(SICI)1097-0215(20000301)85:5<633::AID-IJC6>3.0.CO;2-5,South Korea,Article,Seoul,1,Journal,2-s2.0-0033980085
Panizo-Santos A.,,Predicting metastatic risk of gastrointestinal stromal tumors: Role of cell proliferation and cell cycle regulatory proteins,2000,International Journal of Surgical Pathology,68,10.1177/106689690000800208,Spain,Article,Pamplona,0,Journal,2-s2.0-0034049784
Fukasawa T.,,"Allelic loss of 14q and 22q, NF2 mutation, and genetic instability occur independently of c-kit mutation in gastrointestinal stromal tumor",2000,Japanese Journal of Cancer Research,72,10.1111/j.1349-7006.2000.tb00910.x,Japan;Japan,Article,Kawachi District;Kofu,1,Journal,2-s2.0-0034525682
Isozaki K.,,Germline-activating mutation in the kinase domain of KIT gene in familial gastrointestinal stromal tumors,2000,American Journal of Pathology,211,10.1016/S0002-9440(10)64795-5,Belgium,Article,Brussels,0,Journal,2-s2.0-0033678402
Lux M.,,KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors,2000,American Journal of Pathology,557,10.1016/S0002-9440(10)64946-2,United States;United States,Article,Boston;Boston,0,Journal,2-s2.0-0033883060
O'Leary T.J.,,Loss of heterozygosity at 1p36 predicts poor prognosis in gastrointestinal stromal/smooth muscle tumors,1999,Laboratory Investigation,52,,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-0033387158
Taniguchi M.,,Effect of c-kit mutation on prognosis of gastrointestinal stromal tumors,1999,Cancer Research,487,,Japan,Article,Suita,0,Journal,2-s2.0-0033199890
Aidan Carney J.,,"Gastric stromal sarcoma, pulmonary chondroma, and extra-adrenal paraganglioma (Carney triad): Natural history, adrenocortical component, and possible familial occurrence",1999,Mayo Clinic Proceedings,331,10.4065/74.6.543,United States,Article,Rochester,0,Journal,2-s2.0-0033064974
Lasota J.,,Mutations in exon 11 of c-kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas,1999,American Journal of Pathology,511,10.1016/S0002-9440(10)65250-9,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-0032953812
Ernst S.I.,,KIT mutation portends poor prognosis in gastrointestinal stromal/smooth muscle tumors,1998,Laboratory Investigation,237,,United States,Article,"Washington, D.C.",0,Journal,2-s2.0-0032408616
Nishida T.,,Familial gastrointestinal stromal tumours with germline mutation of the KIT gene [3],1998,Nature Genetics,474,10.1038/1209,Japan,Letter,Suita,0,Journal,2-s2.0-0031848146
Kindblom L.,,Gastrointestinal pacemaker cell tumor (GIPACT): Gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal,1998,American Journal of Pathology,1358,,Sweden,Article,Gothenburg,0,Journal,2-s2.0-0031947592
Hirota S.,,Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors,1998,Science,3514,10.1126/science.279.5350.577,,Article,,0,Journal,2-s2.0-15644363454
Bergmann F.,,Cytogenetic and morphologic characteristics of gastrointestinal stromal tumors. Recurrent rearrangement of chromosome 1 and losses of chromosomes 14 and 22 as common anomalies.,1998,Verhandlungen der Deutschen Gesellschaft für Pathologie,34,,Germany,Article,Aachen,0,Journal,2-s2.0-0032248622
El-Rifai W.,,DNA copy number losses in chromosome 14: An early change in gastrointestinal stromal tumors,1996,Cancer Research,120,,Egypt;Finland,Article,Cairo;Helsinki,0,Journal,2-s2.0-0029900130
Druker B.,,Effects of a selective inhibitor of the Ab1 tyrosine kinase on the growth of Bcr-Ab1 positive cells,1996,Nature Medicine,2951,10.1038/nm0596-561,United States,Article,Portland,0,Journal,2-s2.0-0029947186
Huang E.,,"The hematopoietic growth factor KL is encoded by the SI locus and is the ligand of the c-kit receptor, the gene product of the W locus",1990,Cell,908,10.1016/0092-8674(90)90303-V,United States,Article,Ithaca,0,Journal,2-s2.0-0025077796
Hanks S.,,The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains,1988,Science,3644,10.1126/science.3291115,United States,Article,San Diego,0,Journal,2-s2.0-0023885305
